www.rybrevant.com
Summary
The website provides information about RYBREVANT®, a medication approved for the treatment of advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Associated Brands
IAB Categories
Health & Fitness
IAB Ad Products
Medical and BiotechnologyHealth and Medical ServicesPharmaceuticals
Tags
Creatives
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|